Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 268Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Asclemed USA, Inc.

02 1Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd.

03 3Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.

04 2LETCO MEDICAL, LLC

05 1Medisca Inc.

06 2Pharma Source Direct, Inc.

07 1Productos Quimicos Naturales S.A. de C.V.

08 1Professional Compounding Centers of America dba PCCA

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

PRASTERONE

NDC Package Code : 76420-688

Start Marketing Date : 2018-06-21

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (0.04g/g)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

03

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

PRASTERONE

NDC Package Code : 64025-0015

Start Marketing Date : 2009-12-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

PRASTERONE

NDC Package Code : 64025-0017

Start Marketing Date : 2005-03-04

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (25kg/25kg)

Marketing Category : BULK INGREDIENT

blank

05

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

PRASTERONE

NDC Package Code : 64025-0022

Start Marketing Date : 2023-09-15

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

PRASTERONE

NDC Package Code : 62991-3188

Start Marketing Date : 2023-04-17

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

07

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

PRASTERONE

NDC Package Code : 62991-3205

Start Marketing Date : 2024-01-09

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

08

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

PRASTERONE

NDC Package Code : 38779-0733

Start Marketing Date : 2007-02-13

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

09

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

PRASTERONE

NDC Package Code : 51927-2960

Start Marketing Date : 2020-06-29

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

10

Iran Expo
Not Confirmed
arrow
arrow
Iran Expo
Not Confirmed

PRASTERONE

NDC Package Code : 12875-9930

Start Marketing Date : 2011-03-15

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

Looking for / Prasterone API manufacturers, exporters & distributors?

Prasterone manufacturers, exporters & distributors 1

48

PharmaCompass offers a list of Prasterone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Prasterone manufacturer or Prasterone supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Prasterone manufacturer or Prasterone supplier.

PharmaCompass also assists you with knowing the Prasterone API Price utilized in the formulation of products. Prasterone API Price is not always fixed or binding as the Prasterone Price is obtained through a variety of data sources. The Prasterone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Prasterone

Synonyms

3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one, Spectrum_000661, Specplus_000094, Spectrum2_000359, Spectrum3_000116, Spectrum4_001395

Dehydro-epi-androsterone Manufacturers

A Dehydro-epi-androsterone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dehydro-epi-androsterone, including repackagers and relabelers. The FDA regulates Dehydro-epi-androsterone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dehydro-epi-androsterone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Dehydro-epi-androsterone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Dehydro-epi-androsterone Suppliers

A Dehydro-epi-androsterone supplier is an individual or a company that provides Dehydro-epi-androsterone active pharmaceutical ingredient (API) or Dehydro-epi-androsterone finished formulations upon request. The Dehydro-epi-androsterone suppliers may include Dehydro-epi-androsterone API manufacturers, exporters, distributors and traders.

click here to find a list of Dehydro-epi-androsterone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Dehydro-epi-androsterone NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dehydro-epi-androsterone as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Dehydro-epi-androsterone API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Dehydro-epi-androsterone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Dehydro-epi-androsterone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dehydro-epi-androsterone NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Dehydro-epi-androsterone suppliers with NDC on PharmaCompass.

Dehydro-epi-androsterone Manufacturers | Traders | Suppliers

Dehydro-epi-androsterone Manufacturers, Traders, Suppliers 1
85
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.